Cytokine-induced monocyte MMP-1 is negatively regulated by GSK-3 through a p38 MAPK-mediated decrease in ERK1/2 MAPK

Yahong Zhang1, Larry M Wahl2

  • 1National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

Insights

Glycogen synthase kinase-3 (GSK-3) negatively regulates monocyte production of matrix metalloproteinase-1 (MMP-1). Inhibiting GSK-3 enhances MMP-1, revealing a novel pathway involving protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs).

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Monocytes/macrophages produce matrix metalloproteinases (MMPs), enzymes implicated in connective tissue destruction during chronic inflammation.
  • Understanding the signal transduction pathways regulating MMP production is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of Glycogen synthase kinase-3 (GSK-3) in regulating cytokine-induced MMP-1 production by monocytes.
  • To elucidate the specific signaling pathways, including mitogen-activated protein kinases (MAPKs) and protein kinase C (PKC), involved in this process.

Main Methods:

  • Monocytes were treated with tumor necrosis factor-alpha (TNF-α) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in the presence or absence of GSK-3 inhibitors (SB216763, GSK-3β siRNA), PKC inhibitors (Gö6976), AKT inhibitors (AKT VIII), and MAPK inhibitors (PD98059, SB203580).
  • Production of MMP-1 was quantified.
  • Phosphorylation levels of GSK-3, p38 MAPK, and ERK1/2 MAPK were assessed.

Main Results:

  • Inhibition of GSK-3 significantly enhanced TNF-α- and GM-CSF-induced MMP-1 production.
  • Cytokine-induced GSK-3 phosphorylation and subsequent MMP-1 production were mediated primarily by a PKC pathway.
  • GSK-3 inhibition led to decreased p38 MAPK phosphorylation and increased ERK1/2 MAPK phosphorylation, with ERK1/2 activation being essential for enhanced MMP-1 production.
  • Conversely, p38 MAPK inhibition mimicked GSK-3 inhibition effects on ERK1/2 activation and MMP-1 production.

Conclusions:

  • GSK-3 acts as a negative regulator of cytokine-induced MMP-1 production in monocytes.
  • The PKC-GSK-3-MAPK signaling axis, specifically the interplay between p38 MAPK and ERK1/2, dictates the level of MMP-1 production.
  • Targeting GSK-3 or modulating downstream MAPK pathways may offer therapeutic strategies for inflammatory conditions characterized by excessive connective tissue degradation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.8K